OpenSea Announcement: If You Purchased NFTs on OpenSea, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims against OpenSea resulting from allegations that OpenSea may have issued materially misleading information to the investing public. So What: If you purchased NFTs on OpenSea you may be entitled to compensation […]

Sportradar to Participate in the Morgan Stanley Consumer & Retail Conference

(NASDAQ:SRAD), ST. GALLEN, Switzerland, Dec. 02, 2024 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced that Craig Felenstein, the Company's Chief Financial Officer, will participate in the Morgan Stanley Consumer & Retail Conference

Oracle Sets the Date for its Second Quarter Fiscal Year 2025 Earnings Announcement

Earnings Results to be released on December 9, 2024, After the Close of the Market Oracle Corporation today announced that its second quarter fiscal year 2025 results will be released on Monday, December 9th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to

Thornburg Income Builder Opportunities Trust Announces Distribution

Thornburg Income Builder Opportunities Trust (the “Trust”) (NASDAQ: TBLD) today announced a monthly distribution of $0.10417 per share on the Trust’s common shares, payable on December 20, 2024 to common shareholders of record as of December 12, 2024. https://mma.prnewswire.com/media/1716788/Thornburg_Logo.jpg The Trust’s monthly distribution is shown below: Amount Payable Date Ex-Dividend/Record Date Change from Previous Declaration

Oracle Sets the Date for its Second Quarter Fiscal Year 2025 Earnings Announcement

Earnings Results to be released on December 9, 2024, After the Close of the Market Oracle Corporation today announced that its second quarter fiscal year 2025 results will be released on Monday, December 9th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to

Thornburg Income Builder Opportunities Trust Announces Distribution

Thornburg Income Builder Opportunities Trust (the “Trust”) (NASDAQ: TBLD) today announced a monthly distribution of $0.10417 per share on the Trust's common shares, payable on December 20, 2024 to common shareholders of record as of December 12, 2024. https://mma.prnewswire.com/media/1716788/Thornburg_Logo.jpg The Trust's monthly distribution is shown below: Amount Payable Date Ex-Dividend/Record Date Change from Previous Declaration$0.10417

Rocky Mountain Chocolate Factory Announces Board Changes

DURANGO, Colo., Dec. 02, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), an international franchisor and producer of premium chocolates and other confectionery products, including gourmet caramel apples, is pleased to announce the appointments of Melvin Keating and Al Harper to the Company’s Board of Directors, replacing

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced completion of enrollment of the sentinel cohort of a Phase 2b clinical trial evaluating Vaxart’s oral pill COVID-19 vaccine candidate against an approved mRNA vaccine comparator. The sentinel cohort comprised of 400 participants, with 200 receiving Vaxart’s COVID-19 vaccine

Rocky Mountain Chocolate Factory Announces Board Changes

(NasdaqGM:RMCF), DURANGO, Colo., Dec. 02, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), an international franchisor and producer of premium chocolates and other confectionery products, including gourmet caramel apples, is pleased to announce the appointments of Melvin Keating and Al Harper to the Company's Board of Directors,

Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

(NASDAQ:VXRT), SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced completion of enrollment of the sentinel cohort of a Phase 2b clinical trial evaluating Vaxart's oral pill COVID-19 vaccine candidate against an approved mRNA vaccine comparator. The sentinel cohort comprised of 400 participants, with 200 receiving Vaxart's COVID-19

Scroll to Top